Index by author

November 01, 2023; Volume 90,Issue 11

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Latifi, Mani
1. You have access
  COVID-19: A management update
  Kathryn Bash, MHSc, MSN, APRN-CNP, Gretchen Sacha, PharmD, BCCCP and Mani Latifi, MD
  
  Cleveland Clinic Journal of Medicine November 2023, 90 (11) 677-683; DOI: https://doi.org/10.3949/ccjm.90a.22102
  
  The authors examine current guidelines of the Infectious Diseases Society of America and the National Institutes of Health.
Lindenmeyer, Christina C.
1. You have access
  What is the role for terlipressin in hepatorenal syndrome?
  Stephanie N. Bass, PharmD, Aanchal Kapoor, MD and Christina C. Lindenmeyer, MD
  
  Cleveland Clinic Journal of Medicine November 2023, 90 (11) 664-667; DOI: https://doi.org/10.3949/ccjm.90a.23037
  
  The drug is recommended as a first-line treatment of hepatorenal syndrome-related acute kidney injury, but it is associated with respiratory failure, especially in the setting of albumin administration, and certain comorbidities may increase the risk.